Eric Lefkofsky Tempus Unicorn Funding

Tempus Unicorn is a Chicago-based technology company founded in the year 2015, with the world’s most extensive library of molecular and clinical data. With the high rise in technology, the company uses an operating system to make the data useful and accessible. It also employs specialized doctors to deliver personalized cancer care for patients through analytical and machine learning platform.

Tempus has made much progress within a short time because of Lefkofsky’s risky effort and ambition. As a result of delivering reliable equipment and services from the Unicorn, the Company has then attracted a lot of interest in Chicago tech community and confirmed that Tempus had assembled one of the most massive cancer databases around the globe.

In March 2018, the co-founder Eric Lefkofsky received charity funds amounting to $80 million from a group of new and existing investors with the motive of aiding the campaign in the fight against chronic diseases. The organizations that funded included New Investors Trust Co., Revolution Growth and New Enterprise Associates.

Cancer treatment in Tempus is increasingly at its intersection of computer technology and medicine. The core objective is for each patient to benefit from the treatment of others whose data have been captured by the physicians.

The action plan for dealing with cancer eradication is a technical process since the data is taken out of electronic medical records systems where it is structured using technology and expertise taskforce. Through the operation, rich molecular data is generated then a sequence of their DNA and RNA follows. The team places all the data in one centralized place for execution to ease the process of data analysis.

Tempus is one of the unique medical organizations providing sequencing tests and collecting clinical data about how patients respond to the treatment. Generally, in health care organization, dealing with data-sets can be tedious because of its size and sometimes disorganized. Therefore, Tempus built a series of data to collect, sort and analyze to usher in the age of precision medicine. These data pipelines are essential on a different range of clinical and research applications to move clinical decision support and powering academic research.

Watch youtube channel

Comments are closed.